#pharma
3 stories
Sun Pharma to consider ₹15,000 crore NCD issue
Sun Pharma plans ₹15,000 crore debt sale to fund Organon acquisition bridge loan.
mint · 1m
Wells Fargo's margin finally beats the bar
A small net interest margin win, a Berenberg upgrade for Lilly's spending spree, and a Fed meeting hanging over it all.
CNBC · 2m
Inside RonanRx: Software-Driven Custom GLP-1 Manufacturing
RonanRx is vertically integrating telehealth, software, and drug compounding to deliver personalized, affordable GLP-1 treatments.
Hacker News · 1m